Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.882 | 0.120 | 2 | 201287058 | 3 prime UTR variant | T/C | snv | 0.10 |
|
Neoplasms; Respiratory Tract Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.827 | 0.120 | 2 | 201279205 | intron variant | T/C | snv | 0.72 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.827 | 0.120 | 2 | 201279205 | intron variant | T/C | snv | 0.72 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.160 | 2 | 201258757 | intron variant | ATTCTGTC/- | delins |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.160 | 2 | 201258757 | intron variant | ATTCTGTC/- | delins |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.160 | 2 | 201258757 | intron variant | ATTCTGTC/- | delins |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
0.925 | 0.160 | 2 | 201258757 | intron variant | ATTCTGTC/- | delins |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||||
|
0.925 | 0.080 | 2 | 201276921 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 2 | 201276921 | missense variant | C/T | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
2 | 201285251 | missense variant | G/A | snv | 7.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.925 | 0.200 | 2 | 201287439 | 3 prime UTR variant | T/A | snv | 0.33 |
|
Nervous System Diseases; Wounds and Injuries | 0.010 | 1.000 | 1 | 2020 | 2020 | |||||||
|
0.925 | 0.200 | 2 | 201287439 | 3 prime UTR variant | T/A | snv | 0.33 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | |||||||
|
2 | 201272639 | frameshift variant | -/C | delins |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
2 | 201272639 | frameshift variant | -/C | delins |
|
Neoplasms | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.120 | 2 | 201285277 | missense variant | A/C | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.925 | 0.080 | 2 | 201236992 | intron variant | G/A | snv | 0.55 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.080 | 2 | 201236992 | intron variant | G/A | snv | 0.55 |
|
Immune System Diseases; Nervous System Diseases | 0.010 | 1.000 | 1 | 2010 | 2010 | |||||||
|
0.925 | 0.080 | 2 | 201266864 | intron variant | T/G | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 2 | 201266864 | intron variant | T/G | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 2 | 201258305 | missense variant | C/A;G;T | snv | 2.3E-04; 2.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 2 | 201258305 | missense variant | C/A;G;T | snv | 2.3E-04; 2.4E-05 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.851 | 0.200 | 2 | 201258707 | intron variant | C/T | snv | 0.57 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||
|
0.851 | 0.040 | 2 | 201258272 | missense variant | A/G | snv | 0.66 | 0.65 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.851 | 0.040 | 2 | 201258272 | missense variant | A/G | snv | 0.66 | 0.65 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
|
0.925 | 0.120 | 2 | 201237962 | intron variant | A/G | snv | 0.42 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2011 | 2011 |